| 1-Pyrrolidinecarboxylic acid, 4-oxo-2-(3-thiazolidinylcarbonyl)-, 1,1-diMethylethyl ester, (2R)- |
替格列汀杂质 |
1415908-67-6 |
| Bambuterol HCl Imp.(EP) |
Bambuterol HCl Imp.(EP) |
1391921-22-4 |
| CYP3cide |
PF-4981517 |
1390637-82-7 |
| tert-butyl (3-((2-chloro-5-(trifluoroMethyl)pyriMidin-4-yl)aMino)phenyl)carbaMate |
CO-1686中间体3 |
1374507-23-9 |
| (8S,9R)-5-fluoro-8-(4-fluorophenyl)-9-(1-methyl-1H-1,2,4-triazol-5-yl)-8,9-dihydro-2H-pyrido[4,3,2-de]phthalazin-3(7H)-one tosylate |
TALAZOPARIB TOSYLATE |
1373431-65-2 |
| Zopiclone iMpurity B |
佐匹克隆开环杂质 |
1369509-04-5 |
| 2-Fluoro-4'-[[4-(4-pyridinylMethyl)-1-piperazinyl]Methyl]-α,α-bis(trifluoroMethyl)-[1,1'-biphenyl]-4-Methanol |
化合物 T16929 |
1359164-11-6 |
| 4,5-Dihydro-α,3-diMethyl-5-oxo-1-phenyl-α-sulfo-1H-pyrazole-4-acetic Acid |
依达拉奉P1杂质 |
1357477-99-6 |
| AZD-26 |
6-[4-(1-氨基环丁基)苯基]-5-苯基-3-吡啶甲酰胺 |
1357158-81-6 |
| Cabozantinib Impurity |
Cabozantinib Impurity |
1355031-15-0 |
| Etoricoxib IMpurity |
脱氯依托昔布 |
1350206-14-2 |
| CEP-33779 |
N-[3-(4-甲基-1-哌嗪基)苯基]-8-[4-(甲磺酰基)苯基]-[1,2,4]三唑并[1,5-A]吡啶-2-胺 |
1346168-57-7 |
| Altiratinib |
ALTIRATINIB |
1345847-93-9 |
| Cephalexin Diketopiperazine Monoacid
(Mixture of DiastereoMers) |
头孢氨苄杂质 |
1323247-65-9 |
| Fasudil iMpurity |
法舒地尔杂质 |
1263357-67-0 |
| Sorafenib IMpurity |
索拉非尼杂质 |
1256817-30-7 |
| Edoxaban iMpurities |
依度沙班杂质 |
1255529-34-0 |
| AZD 7762 hydrochloride |
AZD7762 HCL |
1246094-78-9 |
| Solifenacin IMpurity |
索利那新杂质 |
1956436-64-8 |
| LevetiracetaM IMurity (L-2-AMinobutanaMide HCl,S-2-AMinobutanaMide HCl) |
左乙拉西坦杂质 |
1933471-30-7 |
